Glycated hemoglobin predicts all-cause, cardiovascular, and cancer mortality in people without a history of diabetes undergoing coronary angiography.
Diabetes Care 34(6):1355-61 (2011) PMID 21515847 PMCID PMC3114349
Glycated hemoglobin has been suggested to be superior to fasting glucose for the prediction of vascular disease and death from any cause. The aim of the present work was to analyze and compare the predictive value of glycated hemoglobin and fasting glucose on all-cause and cause-specific mortality in subjects who underwent coronary angiography.
DOI: 10.2337/dc10-2010
Version: za2963e q8za0 q8zbd q8zc3 q8zd4 q8zed q8zfd q8zg8